Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

1.

High-dose acetaminophen inhibits the lethal effect of doxorubicin in HepG2 cells: the role of P-glycoprotein and mitogen-activated protein kinase p44/42 pathway.

Manov I, Bashenko Y, Eliaz-Wolkowicz A, Mizrahi M, Liran O, Iancu TC.

J Pharmacol Exp Ther. 2007 Sep;322(3):1013-22. Epub 2007 May 25.

PMID:
17526808
[PubMed - indexed for MEDLINE]
Free Article
2.

The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.

Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt CM.

J Surg Res. 2008 Dec;150(2):219-26. doi: 10.1016/j.jss.2008.01.029. Epub 2008 Mar 3.

PMID:
18468633
[PubMed - indexed for MEDLINE]
3.

Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.

Manov I, Pollak Y, Broneshter R, Iancu TC.

FEBS J. 2011 Sep;278(18):3494-507. doi: 10.1111/j.1742-4658.2011.08271.x.

PMID:
21790999
[PubMed - indexed for MEDLINE]
4.

Involvement of the multidrug resistance P-glycoprotein in acetaminophen-induced toxicity in hepatoma-derived HepG2 and Hep3B cells.

Manov I, Bashenko Y, Hirsh M, Iancu TC.

Basic Clin Pharmacol Toxicol. 2006 Sep;99(3):213-24.

PMID:
16930294
[PubMed - indexed for MEDLINE]
5.

Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer.

Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ.

Int J Oncol. 2010 Jul;37(1):111-23.

PMID:
20514403
[PubMed - indexed for MEDLINE]
6.

Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.

Shinoda C, Maruyama M, Fujishita T, Dohkan J, Oda H, Shinoda K, Yamada T, Miyabayashi K, Hayashi R, Kawagishi Y, Fujita T, Matsui S, Sugiyama E, Muraguchi A, Kobayashi M.

Int J Cancer. 2005 Oct 20;117(1):21-31.

PMID:
15880572
[PubMed - indexed for MEDLINE]
8.

[The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].

Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX, Mao CP.

Zhonghua Wai Ke Za Zhi. 2007 Jul 1;45(13):917-20. Chinese.

PMID:
17953842
[PubMed - indexed for MEDLINE]
9.
10.

Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.

Zaja R, Caminada D, Loncar J, Fent K, Smital T.

Toxicol Appl Pharmacol. 2008 Mar 1;227(2):207-18. Epub 2007 Nov 13.

PMID:
18076962
[PubMed - indexed for MEDLINE]
11.

Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.

Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.

J Pharmacol Exp Ther. 2009 Jun;329(3):1063-70. doi: 10.1124/jpet.108.147306. Epub 2009 Mar 3.

PMID:
19258520
[PubMed - indexed for MEDLINE]
Free Article
12.

Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.

Tong AW, Su D, Mues G, Tillery GW, Goldstein R, Klintmalm G, Stone MJ.

Clin Cancer Res. 1996 Mar;2(3):531-9.

PMID:
9816200
[PubMed - indexed for MEDLINE]
Free Article
13.

Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation.

Kaufmann R, Henklein P, Henklein P, Settmacher U.

Oncol Rep. 2009 May;21(5):1261-7.

PMID:
19360302
[PubMed - indexed for MEDLINE]
14.

Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.

Ding SZ, Smith MF Jr, Goldberg JB.

J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e67-78. doi: 10.1111/j.1440-1746.2007.04912.x.

PMID:
18702686
[PubMed - indexed for MEDLINE]
15.
16.

Reversal of P-glycoprotein mediated multidrug resistance in K562 cell line by a novel synthetic calmodulin inhibitor, E6.

Zhu HJ, Wang JS, Guo QL, Jiang Y, Liu GQ.

Biol Pharm Bull. 2005 Oct;28(10):1974-8.

PMID:
16204958
[PubMed - indexed for MEDLINE]
Free Article
17.

Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.

Matsumoto K, Okano J, Nagahara T, Murawaki Y.

Int J Oncol. 2006 Dec;29(6):1501-8.

PMID:
17088989
[PubMed - indexed for MEDLINE]
19.

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.

Cusimano A, Foderà D, D'Alessandro N, Lampiasi N, Azzolina A, Montalto G, Cervello M.

Cancer Biol Ther. 2007 Sep;6(9):1461-8. Epub 2007 Jun 26.

PMID:
18424914
[PubMed - indexed for MEDLINE]
Free Article
20.

Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma.

Nakajima A, Yamamoto Y, Taura K, Hata K, Fukumoto M, Uchinami H, Yonezawa K, Yamaoka Y.

Int J Oncol. 2004 Mar;24(3):635-45.

PMID:
14767548
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk